The G‐protein‐coupled human cannabinoid receptor 1 (CB1) is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.